PHA 568487 M24500
Specifications
| inquiry |
CAS Number:
527680-56-4
Target:
AChR
Molecular formula:
C16H20N2O3
Formula weight:
288,34
Purity:
>98% (HPLC)
Stability:
≥ 2 years
Product description:
The quinuclidine PHA 568487 is an agonist of the alpha 7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability.
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com
HansaBioMed: leader in exosome based solutions for Life Sciences HansaBioMed OU is an innovative Company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTMplatform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.